DNA damage by nitrogen mustard in a gene containing multiple Sp1-binding sites

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 445, Issue 1, 1999, Pages 45-54

  Chen, Xin Ming ^a   Cullinane, Carleen ^a   Gray, Peter J ^b   Phillips, Don R ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b AERO AND MAR RESEARCH LABORATORY   (Australia)

Author keywords

Alkylating agent; Cytochrome c1 gene; DNA damage; Quantitative PCR; Sp1

Indexed keywords

ALKYLATING AGENT; CHLORMETHINE; CYTOCHROME C1;

ALKYLATION; ARTICLE; BINDING SITE; DNA DAMAGE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTION TIME; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ALKYLATING AGENTS; ALKYLATION; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CYTOCHROMES C1; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MECHLORETHAMINE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0032883918     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00114-X     Document Type: Article

References (34)

1. Hemminki K., Ludlum D.B. Covalent modification of DNA by antineoplastic agents. J. Natl. Cancer Inst. 73:1984;1021-1028.
2. Hemminki K., Kallama S. Reaction of nitrogen mustards with DNA. IARC Sci. Publ. 78:1986;55-70.
3. K. Hemminki, DNA adducts of nitrogen mustards and ehtylene imines, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, H. Bartsch (Eds.), DNA Adducts: Identification and Significance, IARC, Lyon, 1994, pp. 313-321.
4. 6-alkyguanine-DNA alkyltransferase. Carcinogenesis. 7:1986;1203-1206.
5. Osborne M.R., Wilman D.E.V., Lawley P.D. Alkylation of DNA by nitrogen mustard bis(2-chloroethy)methylamine. Chem. Res. Toxicol. 8:1995;316-320.
6. 7 linkage of deoxyguanine residues at the duplex sequence 5′-d(GNC). J. Am. Chem. Soc. 115:1993;2551-2557.
7. Dean S.W., Fox M. DNA repair, DNA synthesis and cell cycle delay in human lymphoblastoid cells differentially sensitive to the cytotoxic effects of nitrogen mustard. Mutat. Res. 132:1984;63-72.
8. Gniazdowski M., Cera C. The effects of DNA covalent adducts on in vitro transcription. Chem. Rev. 96:1996;619-634.
9. Gray P.J., Cullinane C., Phillips D.R. In vitro transcription analysis of DNA alkylation by nitrogen mustard. Biochemistry. 30:1991;8036-8040.
10. Masta A., Gray P.J., Phillips D.R. Nitrogen mustard inhibits transcription and translation in a cell free system. Nucleic Acids Res. 23:1995;3508-3515.
11. Pieper R.O., Fustscher B.W., Erickson L.C. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro. Carcinogenesis. 10:1989;1307-1314.
12. Wassermann K., Damgaard J. Ongoing activity of RNA polymerase II confers preferential repair of nitrogen mustard-induced N-alkypurines in the hamster dihydrofolate reductase gene. Cancer Res. 54:1994;175-181.
13. Welch J.J., Raucher F.J., Beerman T.A. Targeting DNA-binding drugs to sequence-specific transcription factor DNA complex. Differential effects of intercalating and minor groove binding drugs. J. Biol. Chem. 269:1994;31051-31058.
14. Broggini M., D'Incalci M. Modulation of transcription factor-DNA interactions by anticancer drugs. Anti-Cancer Drug Design. 9:1994;373-387.
15. Chen X.-M., Gray P.J., Cullinane C., Phillips D.R. Differential sensitivity of transcription factors to mustard-damaged DNA. Chem.-Biol. Interact. 118:1999;51-67.
16. Huber R., Schlessinger D., Pilia G. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene. Gene. 214:1998;35-44.
17. Vaishnaw A.K., Mitchell T.J., Rose S.J., Walport M.J., Morley B.J. Regulation of transcription of the TATA-less human complement component C4 gene. J. Immunol. 160:1998;4353-4360.
18. Shi Y., Berg J.M. DNA unwinding induced by zinc finger protein binding. Biochemistry. 35:1996;3845-3848.
19. Sjottem E., Andersen C., Johansen T. Structural and functional analyses of DNA bending induced by Sp1 family transcription factors. J. Mol. Biol. 267:1997;490-504.
20. van der Vliet P.C., Verrijzer C.P. Bending of DNA by transcription factors. BioEssays. 15:1993;25-32.
21. Kim J., Klooster S., Shapiro D.J. Intrinsically bend DNA in a eukaryotic transcription factor recognition sequence potentiates transcription activation. J. Biol. Chem. 270:1995;1282-1288.
22. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54:1985;1015-1069.
23. Li R., Luciakova K., Nelson B.D. Expression of the human cytochrome c1 gene is controlled through multiple Sp1-binding sites and an initiator region. Eur. J. Biochem. 241:1996;649-656.
24. Suzuki H., Hosokawa Y., Nishikimi M., Ozawa T. Structural organization of the human mitochondrial cytochrome c1 gene. J. Biol. Chem. 264:1989;1368-1374.
25. K.A. Grimaldi, J.A. Hartley, PCR-based methods for detecting DNA damage and its repair at the subgene and single nucleotide levels in cells, in: K.R. Fox (Ed.), Drug-DNA Interactions Protocol, Humana Press, Totowa, NJ, 1997, pp. 157-180.
26. M. Cain, P. Tenni, Mustine hydrochloride, Drug Therapy in Cancer, The Society of Hospital Pharmacists of Australia, Maryborough, Victoria, Australia, 1992, pp. 279-284.
27. Mattes W.B., Hartley J.A., Kohn K.W., Matheson D.W. GC-rich regions in genomes as targets for DNA alkylation. Carcinogenesis. 9:1988;2065-2072.
28. Millard J.T., Raucher S., Hopkins P.B. Mechlorethamine cross-links deoxyguanosine residues at 5′-GNC sequences in duplex DNA fragments. J. Am. Chem. Soc. 112:1990;2459-2460.
29. Masta A., Gray P.J., Phillips D.R. Molecular basis of nitrogen mustard effects on transcription processes: role of depurination. Nucleic Acids Res. 22:1994;3880-3886.
30. Grimaldi K.A., Bingham J.P., Souhami R.L., Hartley J.A. DNA damage by anticancer agents and its repair: mapping in cells at the subgene level with quantitative polymerase chain reaction. Anal. Biochem. 222:1994;236-242.
31. Hall A.G., Tilby M.J. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev. 6:1992;163-173.
32. Calsou P., Salles B. Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother. Pharmacol. 32:1993;85-89.
33. Hartley J.A., Bingham J.P., Souhami R.L. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells. Nucleic Acids Res. 20:1992;3175-3178.
34. Grimaldi K.A., McAdam S.R., Souhami R.L., Hartley J.A. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells. Nucleic Acids Res. 22:1994;2311-2317.